Looking Ahead at the Neurology Clinical Trial Space in the Post-COVID-19 Landscape, Upcoming Webinar Hosted by Xtalks Share Article In this free webinar, the featured speakers will discuss what neurological clinical trials will look like beyond COVID-19 protocols. It will focus on the recruitment landscape, decentralized landscape and therapeutic landscape. Today’s neurological studies now need to take into account the patient burden, clinical site safety, and even pre-existing neurological conditions caused by the COVID-19 infection to reach successful trial completion. TORONTO (PRWEB) April 07, 2021 For pharmaceutical and medical device companies, navigating the neurology clinical trial space in the wake of COVID-19 requires balancing between critical study milestones and patient safety. With the post-pandemic landscape becoming the new clinical trial status quo, neurology research must now execute the best strategies available to adapt and pivot quickly across all central nervous system (CNS) studies.